Non-Viral Transfection Reagents Market is segmented By Non-Viral Transfection Reagents (Lipid-based Carriers, Polymer-based Carriers, Protein-based Ca....
Market Size in USD
CAGR8.3%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 8.3% |
Market Concentration | Medium |
Major Players | Thermo Fisher Scientific, MaxCyte, MilliporeSigma, Bio-Rad Laboratories, Altogen Biosystems |
The non-viral transfection reagents market is estimated to be valued at USD 687 Mn in 2024 and is expected to reach USD 1,200 Mn by 2031, growing at a compound annual growth rate (CAGR) of 8.3% from 2024 to 2031.
The non-viral transfection reagents market is expected to witness a positive growth trend over the forecast period. The demand for non-viral transfection is higher due to various advantages over viral transfection such as reduced cytotoxicity, immunogenicity, and mutagenicity. Moreover, non-viral methods cause less damage to transfected cells. Advancements in transfection technologies and development of novel products are further expected to support the market growth.